-The Economic Times HYDERABAD: Numerous Pharmacies - especially those operating on rented space - are shutting down across the country, hurt by a sharp decline in margins after the introduction of a new pricing policy for medicines and intense competition from bigger players. The new Drug Price Control Order (DPCO), which was notified on May 15, has made the prices of some 150 drugs fall steeply. Under this, companies and retailers are...
More »SEARCH RESULT
Total Matching Records found : 40
Eviction drive turns deadly, tribal falls victim-Pheroze L Vincent
-The Hindu BHATTIDHANA (M.P.): On July 28, a task force threw out around 70 Gond adivasis from a nursery of fruit trees in a reserve forest in Madhya Pradesh Gond adivasis wiped the wrinkled face of the late Bishan Dhurve with turmeric water, washing away the bits of coagulated blood on his forehead. The wound, his son Dikchand said, was inflicted by the Forest Department, which evicted around 70 tribal people who...
More »Kerala tackles prejudice and prices -C Maya
-The Hindu The State population stands at a little over three crore, but average consumption of drugs is three times the national average In Kerala, where people have a marked preference for branded drugs, where the most expensive brand is considered the best, and only those brands pushed by doctors sell, the new Drug (Prices Control) Order, which is expected to cut prices by 20-25 per cent, may not have much of...
More »Spectre of drug shortage over TB treatment -Rupali Mukherjee
-The Times of India MUMBAI: The treatment of lakhs of tuberculosis (TB) patients, especially children, across the country has been jeopardized over the past few weeks as India battles a severe shortage of key TB drugs. The stock-outs are more to do with two categories: paediatric and drug-resistant TB or DR-TB, industry experts say. Medical experts say that unless the government intervenes immediately, such acute shortage of drugs could prove disastrous for...
More »Hospitals, chemists to wait for regulatory word on Ranbaxy
-PTI Drug regulator DGCI is conducting a "focussed scrutiny" of medicines sold by Ranbaxy and some other drug makers, but says it remains confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products. While the company continues to assert that its drugs meet all regulatory standards, a few hospitals and Pharmacies have adopted a cautious stand on use of its products. However, a majority...
More »
